Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
- |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Obseva Sa
Obseva SA is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for women's reproductive health. The company is involved in the research, development, and production of drugs targeting conditions such as endometriosis, uterine fibroids, and preterm labor. Obseva aims to address the unmet medical needs of women and improve their quality of life through its products and treatments. The company utilizes advanced scientific and clinical expertise to develop safe and effective therapies, with a commitment to improving women's reproductive health worldwide.
Company Address: Chemin des Aulx, 12 Geneva 1228
Company Phone Number: 22 552 38 40 Stock Exchange / Ticker: NASDAQ OBSV
OBSV is expected to report next financial results on March 30, 2024. |
|
|